Clinical Pharmacogenomics in Practice: Personalizing Drug Therapy Through Genetics

Clinical Pharmacogenomics in Practice: Personalizing Drug Therapy Through Genetics

Objectives:

• Quantify the clinical value of pharmacogenomics integration using real implementation experience
• Review the critical role of clinical pharmacists in incorporating pharmacogenomics into routine clinical practice
• Elucidate the considerations for implementing PGx service at a new institution
• Address the potential barriers to widespread adoption of pharmacogenomics

Date: Wednesday – July 08, 2026

Time: 07:00 PM to 8:00 PM

The record is now available 

Speaker: Dr. Hana Al Alshaykh

Dr. Hana Al Alshaykh is a Clinical Pharmacogenomics Specialist and Board‑Certified Pharmacotherapy Specialist. She completed her PharmD at MUSC, PGY1 at KFSHRC, and PGY2 in Clinical Pharmacogenomics at the University of Florida. At KFSHRC, she co-leads pharmacogenomics service implementation, co‑founded the PGx and Precision Medicine Clinics, and mentors trainees in Clinical Pharmacogenomics rotation and research while coordinating the Clinical Pharmacogenomics Subcommittee.